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mate (CDRI Compound 81/470) has consistently exhibited broad-spectrum anthelmintic
efficacy both against adult and larval stages of various helminth parasites of experimental
and domestic animals, by oral and parenteral routes. The compound incorporated in trans-
dermal tapes has also yielded anthelmintic action.
With a view to enhance absorption and consequently the efficacy, a soluble formula-
tion of the compound has been developed and its efficacy was evaluated against various ex-
perimental helminth parasites of rodents (Ancylostoma ceylanicum (adult), Nippostrongylus
brasiliensis (adult and L4), Syphacia obvelatq (adult)) and poultry (Ascaridia galli). This ap-
pears to be the only benzimidazole which could be solubilized.
While the soluble formulation has been found to have comparable efficacy to the pow-
der form against intestinal worms, the efficacy was substantially increased against systemic
parasites (N. brasiliensis L4 stage). The enhanced efficacy by oral route is very well cor-
related with high absorption of drug from soluble formulation which has been demonstrated
by the pharmacokinetic studies reported by Nagaraja et al (1995).
The results of the present study suggest that the soluble formulation may find wider
application in respect to easy administration through drinking water in large herds, flocks







Methyl-[5- {(4-(2-pyridinyl)-l-piperaziriyl)-carbonyl} - l -H-benzimidazol-2-yl]- carbamate
(CDRI Compound 81/470) has consistently exhibited broad-spectrum anthelmintic efficacy both
against adult and larval stages of various helminth parasites of experimental and domestic
animals by oral and parenteral routes (Katiyar et al, 1984, 1987, 1988). The compound in-
corporated in transdermal tape has also shown excellent action (Jain et al, 1991; Gupta et al,
1992).
With a view to enhance bioavailability and consequently the efficacy, a soluble formu-
lation of the compound has been developed (Jain et al, 1994) and evaluated against various
helminth parasites of rodents and poultry.
MATERIALS AND METHODS
Test Parasites, Animals and Treatment:
Compound 81/470 (soluble form) was tested against adult Ancylostoma ceylanicum in
hamsters, adult and larvae of Nippostrongylus brasiliensis in rats, adult Syphada obvelata in
mice and Ascaridia galli in fowl. Simultaneous comparison was made with powder form of the
compound.
Laboratory bred adult male hamsters (50-60 g), newly weaned young male rats of UF
strain (35-40 g), male albino swiss mice (18-20 g) and naturally infected birds (fowl) served
as experimental hosts. Rodents were housed in plastic cages in a climatically controlled
animal house (25-28°C) and had free access to standard rodent food pellets (Lipton India
Ltd.) and water. A. galli infected fowls (ascertained by stool examination) were maintained in
individual cage and were provided with poultry feed and water. The animals were killed
under deep ether anaesthesia.
Preparation of soluble formulation:
lOOmg/ml solution of 81/470 was prepared by dissolving 1 g of compound in 5 ml lactic
acid at room temperature. To the resultant solution 5 ml of distilled water was added, pH of
the solution was adjusted to 3.0 by adding, in portion, solid sodium bicarbonate. The solution
was filtered through a sintered funnel to remove any undissolved or suspended impurities.
Anthelmintic assay:
The powder and soluble forms were simultaneously evaluated.
1. Ancylostoma ceylanicum (hook worm):
The therapeutic efficacy was assessed by the procedure described earlier by Ray et al
(1978) and Katiyar et al (1984, 1987). Hamsters were orally infected with 60±5 infective lar-
vae (L3) of A. ceylanicum. The animals found positive by ovoscopic examination on day 17-
post-infection (p.i.) were used in therapeutic trials. The positive animals of one infected
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b atch were randomly allocated for control and for treatment with both the formulations of com-
pound. The administration of both the formulations, at 6.25, 3.12 & 1.56 mg/kg x 1 dose levels, was
done on any day between day 17 and 20 p. i. The efficacy was expressed in terms of absolute
clearance of parasites from the host and percent wormreduction. The percent wormreduction in
the treated group compared to untreated control group was obtained by the formula (N-n) x
100-=-N (where N and n stand for average numbers of worms in untreared control group and
treated group respectively).
2. Nippostrongylus brasiliensis (Trichostrongylid):
Adultiddal
The rats were infected with 500 L3 subcutaneously (Misra et al. 1981). The therapeutic trials
at 100, 50, 25 and 12.5 mg/kg x 3 days dosage regimen were initiated on day 9 post infection and
continued for three consecutive days. The efficacy assessment was done in the manner described
for A. ceylanicum (adulticidal).
Larvicidal
The larvicidal action was evaluated against L4 stage in lungs as described by Katiyar eh al
(1987) and Gupta eh al (1992). Since the abode of L4 is lung, the formulation of the compound were
tested also by intramuscular route. The two formulations were administered on day two of larval
inoculation at the dose levels of 20 mg/kg x 1 by i. m. and p. o. routes and treated animals were
sacrificed on day 9 p. i.. The adult wormswere enumerated (Katiyar et al, 1987) and efficacy
assessment was made as described above.
3. Syphacia obvelata (Oxyurid):
Adult mice of either sex, 9- 10 months old (25-30 g ) harbouring a natural infection of S.
obvelata were treated with both the formulations at different dose levels (Table 1). The mice freed
from the worms, as observed on sacrifice, formed the basis of drug efficacy (Katiyar et al,
1982).
4. Ascaridia galli (Ascarid):
The adult fowls positive for round worms,wereprocured from local poultry farm. Both the
formulations were assessed by oral route at three dose levels (20, 10 and 5 mg/kgx 1). After
treatment, the stool voided each day was examined for expelled worms.Whenthe wormexpul-
sion ceased the birds were sacrificed and whole of the intestine was slit open and carefully ob-
served for wormsto verify drug's efficacy. Untreated control animals were similarly examined for
the presence of worms in their stool and in'the intestine on sacrifice (Katiyar et al, 1984). Com-
plete cure was the criterion of efficacy.
RESULTS
Efficacy profile
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A. ceylanicum (Adulticidal activity):
Both powder and soluble formulations at single oral dose of 6.25 mg/kg resulted in
complete elimination of parasites. Lower doses yielded dose dependent efficacy (Table 1).
There is no significant difference in activity (p >0.05) between the two formulations at each
dose level.
N. bmsiliensis (Adulticidal activity):
Different log doses of both the formulations were used. 100 mg/kg dose given for three
consecutive days cured all the rats. At lower dose of 25 mg/kgx3, more or less similar ac-
tivity (93-95 %) was recorded with both the formulations. Reduction in dose had propor-
tionate activity.
TV. brasiliensis (Larvicidal activity):
The activity of soluble preparation against L4 stage was significantly enhanced (p<
0.05). The powder form at 20 mg/kgxl dose level exhibited 64.3 % and 78.8 % worm
reduction by i. m. and oral routes respectively while the values with soluble formulation were
69.6 % and 92.0 % (Table 2). By oral route the efficacy of soluble formulation was sig-
nificantly higher (p<0.05) than the powder form, whereas by i. m. route there was no marked
difference in activity (NS).
S. obvelata (Adulticidal activity):
Both the formulations showed similar activity at 100, 50 and 25 mg/kgx 3 dosage regi-
men(Table 1).
A. galli (Adulticidal activity):
All the fowls were successfully cured when treated at 20 and 10 mg/kgx l dose levels
of the two formulations. Proportionally reduced efficacy was recorded at 5 mg/kg x l dose
level (Tablel 1).
DISCUSSIONS
Benzimidazole constitute an important class of anthelmintics, however, they are notori-
ously insoluble in water (Toeco et al, 1965; Sharma and Srivastava, 1988) which limits their
use against systemic parasites. In order to increase bioavailability and consequently the ef-
ficacy, efforts were directed to make a soluble formulation of the compound while retaining
anthelmintic activity. It appears to be the first example amongst the benzimidazole deriva-
tives which could be successfully solubilised without loss of biological activity.
Amongst the four enteric helminths studied, only TV. brasiliensis has systemic migration
and L4 stages inhabitate lungs. Therefore the anthelmintic efficacy of both the formulations
was studied only against L4 stage of TV. brasiliensis. The larvae (L3 of TV brasiliensis after
inoculation in rats reach the lungs, lymph and blood vascular systems 30-36 hr after inocu-
lation and moult to L4. By 65 hr the L4 stages (35% of original L3 dose) are carried to the
lumen of the small intestine where they mature. Eggs appear in the faeces by day 6 following
infection (Haley et al, 1962; Ogilvie and Jones, 1971). To study the action against L4 stage,
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the compound wasadministered after 30-36 hr p. i. (Katiyar et al, 1987; Gupta et al, 1992) and
larvicidal efficacy, which otherwise was indirect, assessed on day 9 p. i..
While the soluble formulation has been found to have comparable efficacy to the powder
form against intestinal worms, the efficacy was substantially increased against systemic parasites
(TV. bmsiliensis L4 stage).
Against L4 stage both the formulations of the compound 81/470 given orally yielded better
efficacy than by parenteral route. The findings are in confirmation of our previous observations
(Katiyar et al, 1987). Enhanced efficacy by oral route could be due to better absorption of the drug
from soluble formulation. It has already been demonstrated by Nagaraja et al (1995) through
pharmacokinetic studies of suspension and soluble formulation that later is 2.14 times better ab-
sorbed than suspension form.
The results of the present study suggest that the soluble formulation may find wider ap-
plication in respect to easy administration through drinking water in large herds/ flocks and
against tissue dwelling parasites especially filarids.
In view of the recent findings, the compound 81/470, having easy chemical synthesis and
better activity profile in soluble form against tissue dwelling parasites, appears to be a strong
candidate anthelmintic for veterinary use.
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